Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ: GLUE · Real-Time Price · USD
4.180
-0.050 (-1.18%)
At close: May 30, 2025, 4:00 PM
4.140
-0.040 (-0.96%)
After-hours: May 30, 2025, 4:04 PM EDT
Monte Rosa Therapeutics Market Cap
Monte Rosa Therapeutics has a market cap or net worth of $258.65 million as of May 30, 2025. Its market cap has increased by 5.60% in one year.
Market Cap
258.65M
Enterprise Value
-34.48M
1-Year Change
5.60%
Ranking
Category
Stock Price
$4.18
Market Cap Chart
Since the IPO on June 24, 2021, Monte Rosa Therapeutics's market cap has decreased from $845.31M to $258.65M, a decrease of -69.40%. That is a compound annual growth rate of -26.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 28, 2025 | 249.73M | -41.43% |
| Dec 31, 2024 | 426.37M | 50.74% |
| Dec 29, 2023 | 282.85M | -23.21% |
| Dec 30, 2022 | 368.32M | -61.22% |
| Dec 31, 2021 | 949.65M | 12.34% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 647.82B |
| Johnson & Johnson | 369.50B |
| AbbVie | 328.16B |
| Novo Nordisk | 305.07B |
| UnitedHealth Group | 270.19B |
| Abbott Laboratories | 231.31B |
| Novartis AG | 219.70B |
| AstraZeneca | 216.88B |